Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Silvia Priska"'
Autor:
Anila Duni, Georgios S. Markopoulos, Ioannis Mallioras, Haralampos Pappas, Efthymios Pappas, Vasileios Koutlas, Eirini Tzalavra, Gerasimos Baxevanos, Silvia Priska, Konstantina Gartzonika, Michael Mitsis, Evangelia Dounousi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe humoral and cellular immune responses to SARS-COV-2 vaccination remain to be elucidated in hemodialysis (HD) patients and kidney transplant recipients (KTRs), considering their baseline immunosuppressed status. The aim of our study was
Externí odkaz:
https://doaj.org/article/26df9da6532049188a5616ea0192b482
Autor:
Stamatia Spyrou, Alexandra Chatzikonstantinou, Archontoula Giannakopoulou, Renia Fotiadou, Silvia Priska, Yannis Simos, Aliki Tsakni, Dimitrios Peschos, Dimitra Houhoula, Epaminondas Voutsas, Haralambos Stamatis
Publikováno v:
Catalysis Research. :1-29
Biomass derived from green marine macroalgae Ulva sp. is considered a rich source of bioactive compounds. In the present study, we demonstrate the increased bioactivity of a phenolic-rich extract derived from green marine macroalgae Ulva intestinalis
Autor:
Anila Duni, Ioannis Mallioras, Georgios Markopoulos, Haralambos Pappas, Efthymios Pappas, Vasileios Koutlas, Eirini Tzalavra, Gerasimos Baxevanos, Silvia Priska, Georgios Katagis, Konstantina Gartzonika, George Vartholomatos, Mixalis Mitsis, Evangelia Ntounousi
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Mortality due to SARS-COV-2 infection in hemodialysis (HD) patients and kidney transplant recipients(KTRs) is high. Despite increased rates of administration of two doses of mRNA vaccines among these vulnerable populations, the ad
Autor:
Vasileios Koutlas, Eirini Tzalavra, Vasileios Tatsis, Anila Duni, Christos Georgopoulos, Haralambos Pappas, Silvia Priska, Mixalis Mitsis, Evangelia Ntounousi
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Kidney transplantation is recognized as the treatment of choice for patients with End Stage Kidney Disease (ESKD). Improvement in short term patient and graft survival of kidney transplant recipients (KTRs), has shifted interest t